Abstract
The coronary microcirculation plays a key role in modulating blood supply to the myocardium. Several factors like myocardial oxygen demands, endothelial and neurogenic conditions determine its function. Although there is available evidence supporting microvascular dysfunction as an important cause of myocardial ischaemia, with both prognostic and symptomatic implications, its diagnosis and management in clinical practice is still relegated to a second plane. Both diagnostic and therapeutic approaches are hampered by the broadness of the concept of microvascular dysfunction, which fails addressing the plurality of mechanisms leading to dysfunction. Normal microcirculatory function requires both structural integrity of the microcirculatory vascular network and preserved signalling pathways ensuring adequate and brisk arteriolar resistance shifts in response to myocardial oxygen demands. Pathological mechanisms affecting these requirements include structural remodelling of microvessels, intraluminal plugging, extravascular compression or vasomotor dysregulation. Importantly, not every diagnostic technique provides evidence on which of these pathophysiological mechanisms is present or predominates in the microcirculation. In this paper we discuss the mechanisms of coronary microvascular dysfunction and the intracoronary tools currently available to detect it, as well as the potential role of each one to unmask the main underlying mechanism.
Similar content being viewed by others
Abbreviations
- Ach:
-
Acetylcholine
- ACS:
-
Acute coronary syndrome
- AMI:
-
Acute myocardial infarction
- CAD:
-
Coronary artery disease
- CBF:
-
Coronary blood flow
- CFR:
-
Coronary flow reserve
- CMR:
-
Cardiac magnetic resonance
- CMVD:
-
Coronary microvascular dysfunction
- cWIA:
-
Coronary wave intensity analysis
- FFR:
-
Fractional flow reserve
- HMR:
-
Hyperemic microvascular resistance
- IHD:
-
Ischaemic heart disease
- IHDVPS:
-
Instantaneous hyperemic diastolic velocity pressure slope
- IMR:
-
Index of microcirculatory resistance
- LVF:
-
Left ventricular function
- MVO:
-
Microvascular obstruction
- MVI:
-
Microvascular injury
- NSTEMI:
-
Non-ST-elevated myocardial infarction
- PCI:
-
Percutaneous coronary intervention
- PET:
-
Positron emission tomography
- Pzf:
-
Zero flow pressure
- STEMI:
-
ST-elevated myocardial infarction
- TMN :
-
Mean transit time
References
Lee JM, Jung J-H, Hwang D, Park J, Fan Y, Na S-H et al (2016) Coronary flow reserve and microcirculatory resistance in patients with intermediate coronary stenosis. J Am Coll Cardiol 67(10):1158–1169
van de Hoef TP, van Lavieren MA, Damman P, Delewi R, Piek MA, Chamuleau SAJ et al (2014) Physiological basis and long-term clinical outcome of discordance between fractional flow reserve and coronary flow velocity reserve in coronary stenoses of intermediate severity. Circ Cardiovasc Interv 7(3):301–311
Gaglia MA, Torguson R, Lipinski MJ, Gai J, Koifman E, Kiramijyan S et al (2016) Frequency of angina pectoris after percutaneous coronary intervention and the effect of metallic stent type. Am J Cardiol 117(4):526–531
Li Y, Yang D, Lu L, Wu D, Yao J, Hu X et al (2015) Thermodilutional confirmation of coronary microvascular dysfunction in patients with recurrent angina after successful percutaneous coronary intervention. Can J Cardiol 31(8):989–997
Herrmann J, Kaski JC, Lerman A (2012) Coronary microvascular dysfunction in the clinical setting: from mystery to reality. Eur Heart J 33(22):2771–2782b
Pries AR, Badimon L, Bugiardini R, Camici PG, Dorobantu M, Duncker DJ et al (2015) Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation. Eur Heart J 36(45):3134–3146
Tonino PAL, De Bruyne B, Pijls NHJ, Siebert U, Ikeno F, van’ t Veer M et al (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360(3):213–224
Pijls NHJ, Fearon WF, Tonino PAL, Siebert U, Ikeno F, Bornschein B et al (2010) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 56(3):177–184
Pijls NHJ, van Schaardenburgh P, Manoharan G, Boersma E, Bech J-W, van’t Veer M et al (2007) Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol 49(21):2105–2111
Davies JE, Sen S, Dehbi H-M, Al-Lamee R, Petraco R, Nijjer SS et al (2017) Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. N Engl J Med. 376(19):1824–1834. doi:10.1056/NEJMoa1700445
Götberg M, Christiansen EH, Gudmundsdottir IJ, Sandhall L, Danielewicz M, Jakobsen L et al (2017) Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. N Engl J Med. 376(19):1813–1823. doi:10.1056/NEJMoa1616540
Escaned J, Echavarría-Pinto M (2014) Moving beyond coronary stenosis: has the time arrived to address important physiological questions not answered by fractional flow reserve alone? Circ Cardiovasc Interv 7(3):282–284
Echavarria-Pinto M, Escaned J, Macías E, Medina M, Gonzalo N, Petraco R et al (2013) Disturbed coronary hemodynamics in vessels with intermediate stenoses evaluated with fractional flow reserve: a combined analysis of epicardial and microcirculatory involvement in ischemic heart disease. Circulation 128(24):2557–2566
Murthy VL, Naya M, Taqueti VR, Foster CR, Gaber M, Hainer J et al (2014) Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation 129(24):2518–2527
Bassingthwaighte JB, Yipintsoi T, Harvey RB (1974) Microvasculature of the dog left ventricular myocardium. Microvasc Res 7(2): 229–249
Komaru T, Kanatsuka H, Shirato K (2000) Coronary microcirculation: physiology and pharmacology. Pharmacol Ther 86(3):217–261
Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HA (2001) Microcirculation in hypertension: a new target for treatment? Circulation 104(6):735–740
Maron BJ, Wolfson JK, Epstein SE, Roberts WC (1986) Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8(3):545–557
Mulvany MJ (2012) Small artery remodelling in hypertension. Basic Clin Pharmacol Toxicol 110(1):49–55
Neglia D, Fommei E, Varela-Carver A, Mancini M, Ghione S, Lombardi M et al (2011) Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension. J Hypertens 29(2):364–372
Crea F, Camici PG, Bairey Merz CN (2014) Coronary microvascular dysfunction: an update. Eur Heart J 35(17):1101–1111
Escaned J, Flores A, García-Pavía P, Segovia J, Jimenez J, Aragoncillo P et al (2009) Assessment of microcirculatory remodeling with intracoronary flow velocity and pressure measurements: validation with endomyocardial sampling in cardiac allografts. Circulation 120(16):1561–1568
Sorop O, Merkus D, de Beer VJ, Houweling B, Pistea A, McFalls EO et al (2008) Functional and structural adaptations of coronary microvessels distal to a chronic coronary artery stenosis. Circ Res 102(7):795–803
Camici PG, Olivotto I, Rimoldi OE (2012) The coronary circulation and blood flow in left ventricular hypertrophy. J Mol Cell Cardiol 52(4):857–864
Schwartzkopff B, Frenzel H, Dieckerhoff J, Betz P, Flasshove M, Schulte HD et al (1992) Morphometric investigation of human myocardium in arterial hypertension and valvular aortic stenosis. Eur Heart J 13 Suppl D:17–23
Elliott PM, Kindler H, Shah JS, Sachdev B, Rimoldi OE, Thaman R et al (2006) Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A. Heart Br Card Soc 92(3):357–360
Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S et al (2001) Safety and efficacy of recombinant human alpha-galactosidase A—replacement therapy in Fabry’s disease. N Engl J Med 345(1):9–16
Tsagalou EP, Anastasiou-Nana M, Agapitos E, Gika A, Drakos SG, Terrovitis JV et al (2008) Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. J Am Coll Cardiol 52(17):1391–1398
Antonios TF, Kaski JC, Hasan KM, Brown SJ, Singer DR (2001) Rarefaction of skin capillaries in patients with anginal chest pain and normal coronary arteriograms. Eur Heart J 22(13):1144–1148
Hinkel R, Hoewe A, Renner S, Ng J, Lee S, Klett K et al (2017) Diabetes mellitus-induced microvascular destabilization in the myocardium. J Am Coll Cardiol 69(2):131–143
Félétou M, Köhler R, Vanhoutte PM (2012) Nitric oxide: orchestrator of endothelium-dependent responses. Ann Med 44(7):694–716
Duncker DJ, Bache RJ (2008) Regulation of coronary blood flow during exercise. Physiol Rev 88(3):1009–1086
Ong P, Athanasiadis A, Mahrholdt H, Borgulya G, Sechtem U, Kaski JC (2012) Increased coronary vasoconstrictor response to acetylcholine in women with chest pain and normal coronary arteriograms (cardiac syndrome X). Clin Res Cardiol 101(8):673–681
Matsuda K, Teragawa H, Fukuda Y, Ueda K, Higashi Y, Sakai K et al (2003) Response of the left anterior descending coronary artery to acetylcholine in patients with chest pain and angiographically normal coronary arteries. Am J Cardiol 92(12):1394–1398
Marzilli M, Sambuceti G, Fedele S, L’Abbate A (2000) Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina. J Am Coll Cardiol 35(2):327–334
Ong P, Athanasiadis A, Borgulya G, Vokshi I, Bastiaenen R, Kubik S et al (2014) Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries. Circulation 129(17):1723–1730
Camici PG, d’Amati G, Rimoldi O (2015) Coronary microvascular dysfunction: mechanisms and functional assessment. Nat Rev Cardiol 12(1):48–62
Chilian WM, Kuo L, DeFily DV, Jones CJ, Davis MJ (1993) Endothelial regulation of coronary microvascular tone under physiological and pathophysiological conditions. Eur Heart J 14 Suppl I:55–59
Choudhury L, Rosen SD, Patel D, Nihoyannopoulos P, Camici PG (1997) Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography. Eur Heart J 18(1):108–116
Betgem RP, de Waard GA, Nijveldt R, Beek AM, Escaned J, van Royen N (2015) Intramyocardial haemorrhage after acute myocardial infarction. Nat Rev Cardiol 12(3):156–167
Teunissen PFA, de Waard GA, Hollander MR, Robbers LFHJ, Danad I, Biesbroek PS et al (2015) Doppler-derived intracoronary physiology indices predict the occurrence of microvascular injury and microvascular perfusion deficits after angiographically successful primary percutaneous coronary intervention. Circ Cardiovasc Interv 8(3):e001786
Patel N, Petraco R, Dall’Armellina E, Kassimis G, De Maria GL, Dawkins S et al (2015) Zero-flow pressure measured immediately after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction provides the best invasive index for predicting the extent of myocardial infarction at 6 months: an OxAMI study (Oxford Acute Myocardial Infarction). JACC Cardiovasc Interv 8(11):1410–1421
Hollander MR, de Waard GA, Konijnenberg LSF, Meijer-van Putten RME, van den Brom CE, Paauw N et al (2016) Dissecting the effects of ischemia and reperfusion on the coronary microcirculation in a rat model of acute myocardial infarction. PLoS ONE 11(7):e0157233
de Waard GA, Hollander MR, Teunissen PFA, Jansen MF, Eerenberg ES, Beek AM et al (2016) Changes in coronary blood flow after acute myocardial infarction: insights from a patient study and an experimental porcine model. JACC Cardiovasc Interv 9(6):602–613
Amier RP, Teunissen PFA, Marques KM, Knaapen P, van Royen N (2014) Invasive measurement of coronary microvascular resistance in patients with acute myocardial infarction treated by primary PCI. Heart Br Card Soc 100(1):13–20
Bekkers SCAM, Smulders MW, Passos VL, Leiner T, Waltenberger J, Gorgels APM et al (2010) Clinical implications of microvascular obstruction and intramyocardial haemorrhage in acute myocardial infarction using cardiovascular magnetic resonance imaging. Eur Radiol 20(11):2572–2578
Kotani J, Nanto S, Mintz GS, Kitakaze M, Ohara T, Morozumi T et al (2002) Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 106(13):1672–1677
Li J, Wu L, Tian X, Zhang J, Shi Y (2015) Intravascular ultrasound observation of the mechanism of no-reflow phenomenon in acute myocardial infarction. PLoS ONE 10(6):e0119223
Hamirani YS, Wong A, Kramer CM, Salerno M (2014) Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis. JACC Cardiovasc Imaging 7(9):940–952
Perazzolo Marra M, Lima JAC, Iliceto S (2011) MRI in acute myocardial infarction. Eur Heart J 32(3):284–293
Taylor AJ, Al-Saadi N, Abdel-Aty H, Schulz-Menger J, Messroghli DR, Friedrich MG (2004) Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging. Circulation 109(17):2080–2085
Anderson JL, Karagounis LA, Califf RM (1996) Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction. Am J Cardiol 78(1):1–8
Nijveldt R, Beek AM, Hirsch A, Stoel MG, Hofman MBM, Umans VAWM et al (2008) Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol 52(3):181–189
Faile BA, Guzzo JA, Tate DA, Nichols TC, Smith SC, Dehmer GJ (2000) Effect of sex, hemodynamics, body size, and other clinical variables on the corrected thrombolysis in myocardial infarction frame count used as an assessment of coronary blood flow. Am Heart J 140(2):308–314
Gibson CM, Ryan KA, Kelley M, Rizzo MJ, Mesley R, Murphy S et al (1999) Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. The TIMI Study Group. Am Heart J 137(6):1179–1184
Gibson CM, Cannon CP, Daley WL, Dodge JT, Alexander B, Marble SJ et al (1996) TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93(5):879–888
Ishihara M, Sato H, Tateishi H, Kawagoe T, Yoshimura M, Muraoka Y (1993) Impaired coronary flow reserve immediately after coronary angioplasty in patients with acute myocardial infarction. Br Heart J 69(4):288–292
Abaci A, Oguzhan A, Eryol NK, Ergin A (1999) Effect of potential confounding factors on the thrombolysis in myocardial infarction (TIMI) trial frame count and its reproducibility. Circulation 100(22):2219–2223
Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ et al (2000) Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101(2):125–130
van’t Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F (1998) Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 97(23):2302–2306
Stone GW, Peterson MA, Lansky AJ, Dangas G, Mehran R, Leon MB (2002) Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 39(4):591–597
Hoffmann R, Haager P, Lepper W, Franke A, Hanrath P (2003) Relation of coronary flow pattern to myocardial blush grade in patients with first acute myocardial infarction. Heart Br Card Soc 89(10):1147–1151
Patel B, Fisher M (2010) Therapeutic advances in myocardial microvascular resistance: unravelling the enigma. Pharmacol Ther 127(2):131–147
Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD (1990) Effects of adenosine on human coronary arterial circulation. Circulation 82(5):1595–1606
Hasdai D, Gibbons RJ, Holmes DR, Higano ST, Lerman A (1997) Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 96(10):3390–3395
Wei J, Mehta PK, Johnson BD, Samuels B, Kar S, Anderson RD et al (2012) Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women’s Ischemia Syndrome Evaluation) study. JACC Cardiovasc Interv 5(6):646–653
Sara JD, Widmer RJ, Matsuzawa Y, Lennon RJ, Lerman LO, Lerman A (2015) Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease. JACC Cardiovasc Interv 8(11):1445–1453
Cemin R, Erlicher A, Fattor B, Pitscheider W, Cevese A (2008) Reduced coronary flow reserve and parasympathetic dysfunction in patients with cardiovascular syndrome X. Coron Artery Dis 19(1):1–7
Aslan G, Sade LE, Yetis B, Bozbas H, Eroglu S, Pirat B et al (2013) Flow in the left anterior descending coronary artery in patients with migraine headache. Am J Cardiol 112(10):1540–1544
Chade AR, Brosh D, Higano ST, Lennon RJ, Lerman LO, Lerman A (2006) Mild renal insufficiency is associated with reduced coronary flow in patients with non-obstructive coronary artery disease. Kidney Int 69(2):266–271
Di Franco A, Lanza GA, Di Monaco A, Sestito A, Lamendola P, Nerla R et al (2012) Coronary microvascular function and cortical pain processing in patients with silent positive exercise testing and normal coronary arteries. Am J Cardiol 109(12):1705–1710
Tondi P, Santoliquido A, Di Giorgio A, Sestito A, Sgueglia GA, Flore R et al (2011) Endothelial dysfunction as assessed by flow-mediated dilation in patients with cardiac syndrome X: role of inflammation. Eur Rev Med Pharmacol Sci 15(9):1074–1077
Recio-Mayoral A, Rimoldi OE, Camici PG, Kaski JC (2013) Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease. JACC Cardiovasc Imaging 6(6):660–667
Taqueti VR, Ridker PM (2013) Inflammation, coronary flow reserve, and microvascular dysfunction: moving beyond cardiac syndrome X. JACC Cardiovasc Imaging 6(6):668–671
Pepine CJ, Anderson RD, Sharaf BL, Reis SE, Smith KM, Handberg EM et al (2010) Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study. J Am Coll Cardiol 55(25):2825–2832
Halcox JPJ, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA et al (2002) Prognostic value of coronary vascular endothelial dysfunction. Circulation 106(6):653–658
Vermeltfoort IAC, Teule GJJ, van Dijk AB, Muntinga HJ, Raijmakers PGHM (2012) Long-term prognosis of patients with cardiac syndrome X: a review. Neth Heart J 20(9):365–371
Marinescu MA, Löffler AI, Ouellette M, Smith L, Kramer CM, Bourque JM (2015) Coronary microvascular dysfunction, microvascular angina, and treatment strategies. JACC Cardiovasc Imaging 8(2):210–220
Meuwissen M, Chamuleau SAJ, Siebes M, de Winter RJ, Koch KT, Dijksman LM et al (2008) The prognostic value of combined intracoronary pressure and blood flow velocity measurements after deferral of percutaneous coronary intervention. Catheter Cardiovasc Interv 71(3):291–297
Förstermann U, Sessa WC (2012) Nitric oxide synthases: regulation and function. Eur Heart J 33(7):829–837, 837a–837d
Dhawan SS, Corban MT, Nanjundappa RA, Eshtehardi P, McDaniel MC, Kwarteng CA et al (2012) Coronary microvascular dysfunction is associated with higher frequency of thin-cap fibroatheroma. Atherosclerosis 223(2):384–388
Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J et al (2012) Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation 126(15):1858–1868
Waard G de, Teunissen PF, Hollander MR, Jansen MF, Robbers L, Knaapen P et al (2014) Abstract 20337: implications of invasively measured coronary flow reserve on infarct size directly following reperfusion after acute myocardial infarction in both humans and an experimental pig model. Circulation 130(Suppl 2):A20337–A20337
Meimoun P, Malaquin D, Benali T, Boulanger J, Zemir H, Sayah S et al (2009) Non-invasive coronary flow reserve after successful primary angioplasty for acute anterior myocardial infarction is an independent predictor of left ventricular recovery and in-hospital cardiac events. J Am Soc Echocardiogr 22(9):1071–1079
Schwartz RS, Burke A, Farb A, Kaye D, Lesser JR, Henry TD et al (2009) Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathology. J Am Coll Cardiol 54(23):2167–2173
Cuculi F, De Maria GL, Meier P, Dall’Armellina E, de Caterina AR, Channon KM et al (2014) Impact of microvascular obstruction on the assessment of coronary flow reserve, index of microcirculatory resistance, and fractional flow reserve after ST-segment elevation myocardial infarction. J Am Coll Cardiol 64(18):1894–1904
Klug G, Mayr A, Schenk S, Esterhammer R, Schocke M, Nocker M et al (2012) Prognostic value at 5 years of microvascular obstruction after acute myocardial infarction assessed by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 14:46
Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG (2003) Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 349(11):1027–1035
Johnson NP, Gould KL (2012) Integrating noninvasive absolute flow, coronary flow reserve, and ischemic thresholds into a comprehensive map of physiological severity. JACC Cardiovasc Imaging 5(4):430–440
van de Hoef TP, Echavarría-Pinto M, van Lavieren MA, Meuwissen M, Serruys PWJC, Tijssen JGP et al (2015) Diagnostic and prognostic implications of coronary flow capacity: a comprehensive cross-modality physiological concept in ischemic heart disease. JACC Cardiovasc Interv 8(13):1670–1680
Meuwissen M, Chamuleau SA, Siebes M, Schotborgh CE, Koch KT, de Winter RJ et al (2001) Role of variability in microvascular resistance on fractional flow reserve and coronary blood flow velocity reserve in intermediate coronary lesions. Circulation 103(2):184–187
Di Mario C, Serruys PW (1995) Principles of interpretation of coronary velocity and pressure tracings. Eur Heart J 16 Suppl J:53–59
Seiler C, Kirkeeide RL, Gould KL (1992) Basic structure-function relations of the epicardial coronary vascular tree. Basis of quantitative coronary arteriography for diffuse coronary artery disease. Circulation 85(6):1987–2003
Seiler C, Kirkeeide RL, Gould KL (1993) Measurement from arteriograms of regional myocardial bed size distal to any point in the coronary vascular tree for assessing anatomic area at risk. J Am Coll Cardiol 21(3):783–797
Barbato E, Aarnoudse W, Aengevaeren WR, Werner G, Klauss V, Bojara W et al (2004) Validation of coronary flow reserve measurements by thermodilution in clinical practice. Eur Heart J 25(3):219–223
Carrick D, Haig C, Ahmed N, Carberry J, Teng Yue May V, McEntegart M et al (2016) Comparative prognostic utility of indices of microvascular function alone or in combination in patients with an acute ST-segment elevation myocardial infarction. Circulation 134(23):1833–1847
McGeoch R, Watkins S, Berry C, Steedman T, Davie A, Byrne J et al (2010) The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 3(7):715–722
van’t Veer M, Adjedj J, Wijnbergen I, Tóth GG, Rutten MCM, Barbato E et al (2016) Novel monorail infusion catheter for volumetric coronary blood flow measurement in humans: in vitro validation. EuroIntervention 12(6):701–707
Wijnbergen I, van’t Veer M, Lammers J, Ubachs J, Pijls NHJ (2016) Absolute coronary blood flow measurement and microvascular resistance in ST-elevation myocardial infarction in the acute and subacute phase. Cardiovasc Revasc Med 17(2):81–87
Bellamy RF (1978) Diastolic coronary artery pressure-flow relations in the dog. Circ Res 43(1):92–101
Mancini GB, McGillem MJ, DeBoe SF, Gallagher KP (1989) The diastolic hyperemic flow versus pressure relation. A new index of coronary stenosis severity and flow reserve. Circulation 80(4):941–950
Di Mario C, Krams R, Gil R, Serruys PW (1994) Slope of the instantaneous hyperemic diastolic coronary flow velocity-pressure relation. A new index for assessment of the physiological significance of coronary stenosis in humans. Circulation 90(3):1215–1224
Mancini GB, Cleary RM, DeBoe SF, Moore NB, Gallagher KP (1991) Instantaneous hyperemic flow-versus-pressure slope index. Microsphere validation of an alternative to measures of coronary reserve. Circulation 84(2):862–870
Cleary RM, Ayon D, Moore NB, DeBoe SF, Mancini GB (1992) Tachycardia, contractility and volume loading alter conventional indexes of coronary flow reserve, but not the instantaneous hyperemic flow versus pressure slope index. J Am Coll Cardiol 20(5):1261–1269
Cleary RM, Moore NB, DeBoe SF, Mancini GB (1993) Sensitivity and reproducibility of the instantaneous hyperemic flow versus pressure slope index compared to coronary flow reserve for the assessment of stenosis severity. Am Heart J 126(1):57–65
Escaned J, Colmenárez H, Ferrer MC, Gutiérrez M, Jiménez-Quevedo P, Hernández R et al (2009) Diastolic dysfunction in diabetic patients assessed with Doppler echocardiography: relationship with coronary atherosclerotic burden and microcirculatory impairment. Rev Esp Cardiol 62(12):1395–1403
Pijls NH, Bech GJ, De Bruyne B, van Straten A (1997) Clinical assessment of functional stenosis severity: use of coronary pressure measurements for the decision to bypass a lesion. Ann Thorac Surg 63(6 Suppl):S6–S11
Zhang Z, Takarada S, Molloi S (2011) Assessment of coronary microcirculation in a swine animal model. Am J Physiol Heart Circ Physiol 301(2):H402–H408
Tanaka N, Takazawa K, Takeda K, Aikawa M, Shindo N, Amaya K, et al (2003) Coronary flow–pressure relationship distal to epicardial stenosis. Circ J 67(6):525–529
Shimada K, Sakanoue Y, Kobayashi Y, Ehara S, Hirose M, Nakamura Y et al (2003) Assessment of myocardial viability using coronary zero flow pressure after successful angioplasty in patients with acute anterior myocardial infarction. Heart Br Card Soc 89(1):71–76
Van Herck PL, Carlier SG, Claeys MJ, Haine SE, Gorissen P, Miljoen H et al (2007) Coronary microvascular dysfunction after myocardial infarction: increased coronary zero flow pressure both in the infarcted and in the remote myocardium is mainly related to left ventricular filling pressure. Heart Br Card Soc 93(10):1231–1237
Parker KH, Jones CJ (1990) Forward and backward running waves in the arteries: analysis using the method of characteristics. J Biomech Eng 112(3):322–326
Davies JE, Whinnett ZI, Francis DP, Manisty CH, Aguado-Sierra J, Willson K et al (2006) Evidence of a dominant backward-propagating “suction” wave responsible for diastolic coronary filling in humans, attenuated in left ventricular hypertrophy. Circulation 113(14):1768–1778
Ladwiniec A, White PA, Nijjer SS, O’Sullivan M, West NEJ, Davies JE et al (2016) Diastolic backward-traveling decompression (suction) wave correlates with simultaneously acquired indices of diastolic function and is reduced in left ventricular stunning. Circ Cardiovasc Interv 9(9). pii: e003779
Davies JE, Sen S, Broyd C, Hadjiloizou N, Baksi J, Francis DP et al (2011) Arterial pulse wave dynamics after percutaneous aortic valve replacement: fall in coronary diastolic suction with increasing heart rate as a basis for angina symptoms in aortic stenosis. Circulation 124(14):1565–1572
Rolandi MC, Wiegerinck EMA, Casadonte L, Yong Z-Y, Koch KT, Vis M et al (2016) Transcatheter replacement of stenotic aortic valve normalizes cardiac-coronary interaction by restoration of systolic coronary flow dynamics as assessed by wave intensity analysis. Circ Cardiovasc Interv 9(4):e002356
Lockie TPE, Rolandi MC, Guilcher A, Perera D, De Silva K, Williams R et al (2012) Synergistic adaptations to exercise in the systemic and coronary circulations that underlie the warm-up angina phenomenon. Circulation 126(22):2565–2574
Rolandi MC, Nolte F, van de Hoef TP, Remmelink M, Baan J, Piek JJ et al (2012) Coronary wave intensity during the Valsalva manoeuvre in humans reflects altered intramural vessel compression responsible for extravascular resistance. J Physiol 590(18):4623–4635
Camici P, Chiriatti G, Lorenzoni R, Bellina RC, Gistri R, Italiani G et al (1991) Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 17(4):879–886
Petersen SE, Jerosch-Herold M, Hudsmith LE, Robson MD, Francis JM, Doll HA et al (2007) Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 115(18):2418–2425
Broyd CJ, Nijjer S, Sen S, Petraco R, Jones S, Al-Lamee R et al (2016) Estimation of coronary wave intensity analysis using noninvasive techniques and its application to exercise physiology. Am J Physiol Heart Circ Physiol 310(5):H619–H627
Mohri M, Koyanagi M, Egashira K, Tagawa H, Ichiki T, Shimokawa H et al (1998) Angina pectoris caused by coronary microvascular spasm. Lancet 351(9110):1165–1169
Ong P, Athanasiadis A, Borgulya G, Mahrholdt H, Kaski JC, Sechtem U (2012) High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol 59(7):655–662
Zeiher AM, Drexler H, Wollschläger H, Just H (1991) Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 84(5):1984–1992
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Mejía-Rentería, H., van der Hoeven, N., van de Hoef, T.P. et al. Targeting the dominant mechanism of coronary microvascular dysfunction with intracoronary physiology tests. Int J Cardiovasc Imaging 33, 1041–1059 (2017). https://doi.org/10.1007/s10554-017-1136-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-017-1136-9